Company news
Lifeward Ltd. (NASDAQ:LFWD) news
Lifeward Ltd. news releases on 6ix. Latest, Sep 8, 2026: Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
Press releases & updates
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
September 8, 2026
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
August 31, 2026
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
August 14, 2026
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
August 7, 2026
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
August 5, 2026
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 7, 2026
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
May 18, 2026
Lifeward Reports First Quarter 2026 Financial Results
May 14, 2026
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
May 4, 2026
Lifeward Successfully Closes on Strategic Partnership with Oramed
March 25, 2026
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
March 13, 2026
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 11, 2026
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 9, 2026
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
March 1, 2026
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
February 24, 2026
Lifeward Announces Reverse Share Split
February 20, 2026
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
February 17, 2026
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
December 17, 2025
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
December 3, 2025
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
November 17, 2025
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
November 14, 2025
Lifeward to Report Third Quarter Financial Results on November 14, 2025
November 10, 2025
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
September 9, 2025
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
September 8, 2025
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 14, 2025
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
August 13, 2025
Lifeward to Report Second Quarter Financial Results on August 14, 2025
August 7, 2025
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
August 4, 2025
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
July 7, 2025
Lifeward Announces Closing of $2.6 Million Public Offering
June 26, 2025
Lifeward Announces Pricing of $2.6 Million Public Offering
June 25, 2025
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
June 24, 2025
Lifeward Names Mark Grant as New CEO
May 19, 2025
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
May 19, 2025
Lifeward Ltd. Reports First Quarter 2025 Financial Results
May 15, 2025
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
May 8, 2025
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
May 7, 2025
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
April 29, 2025
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
April 24, 2025
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
April 15, 2025
FDA Issues Clearance for ReWalk 7 Exoskeleton
March 13, 2025
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
March 7, 2025
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
March 6, 2025
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
March 5, 2025
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
February 28, 2025
Lifeward Announces CEO Transition
February 19, 2025